IPO

Gujarat Kidney & Super Speciality IPO to Raise INR 250.80 Cr for Expansion Plans December 21, 2025 Gujarat Kidney and Super Speciality Limited’s initial public offering will open for public subscription on December 22 and close on December 24. The healthcare company plans to use the proceeds for hospital acquisitions, expansion, and debt repayment.

Practo Explores Banks for Potential 2026 IPO December 20, 2025 Practo is said to be exploring a potential IPO in 2026 and has begun early discussions with advisers, reflecting strong momentum in India’s IPO market and growing investor interest in digital health platforms.

Molbio Diagnostics gets SEBI approval for INR 200 Cr IPO December 11, 2025 Molbio Diagnostics has received SEBI approval to proceed with its INR 200 crore IPO, which includes a fresh issue of shares and an OFS by existing investors. The company will use the capital to strengthen R&D, establish a Centre of Excellence, and upgrade manufacturing. Molbio reported INR 1,020 crore in revenue and INR 138.5 crore profit in FY25, driven by strong adoption of its Truenat portable PCR platform.

Nephrocare Health to Launch INR 871 Cr IPO on December 10 December 4, 2025 NephroPlus, operated by Nephrocare Health, will be opening its IPO on December 10 to raise ₹871 crore through a fresh issue and offer for sale.

Manipal Health Eyeing $1 Bn IPO, Plans for January Listing December 4, 2025 Manipal Health Enterprises is preparing to file for a $1 billion IPO in January, according to people familiar with the matter. The move positions the hospital network for what could be India’s biggest public listing by a healthcare operator.

Integris Medtech Files DHRP with SEBI for INR 3500-4000 Cr IPO October 13, 2025 Leading Medtech Company Integris Medtech has filed its DHRP with SEBI to raise between INR 3,500 crore and INR 4,000 crore via an initial public offering. The offering includes a fresh issue of about INR 925 crore and an Offer for Sale (OFS) by promoters and existing shareholders. The company plans to use the fresh proceeds primarily for debt repayment and general corporate purposes.

Medicover Hospitals Eyes IPO in 2026, Announces Expansion in Telangana September 17, 2025 Medicover Hospitals plans a 2026 IPO and announces two new multi-specialty hospitals in Hyderabad, with a turnover target of Rs 2,000 crore for the current financial year.

Amanta Healthcare Launches INR 126 Cr IPO August 27, 2025 Amanta Healthcare has launched a ₹126 crore IPO through a fresh issue of 1 crore shares, with a price band of ₹120–₹126 per share. The listing is scheduled for September 4, 2025, on BSE and NSE.

Valuation of Manipal Hospitals Rises to $13 Bn After Sahyadri Deal; IPO Eyed for 2026 July 14, 2025 Manipal Hospitals’ valuation has jumped to around $13 Bn following its acquisition of Sahyadri Hospitals. The Temasek-backed hospital chain is expected to file draft papers for a $1 Bn IPO by June 2025, targeting a listing before March 2026.

Anthem Biosciences to Launch INR 3,395 Cr IPO on July 14 July 10, 2025 Anthem Biosciences will launch its INR 3,395 Cr IPO on July 14, through an offer-for-sale route. The Bengaluru-based CRDMO firm, with global clients across 44 countries, has set the price band at INR 540–INR 570. Anchor bidding opens July 11 ahead of its market debut.

Sudeep Pharma Files DRHP with SEBI for IPO June 26, 2025 Vadodara-based Sudeep Pharma has filed draft IPO papers with SEBI, proposing a INR 95 Cr fresh issue and an offer for sale of over 1 Cr shares. Funds will be used for capacity expansion and machinery procurement.

Biocon CEO Rules Out Immediate Biocon Biologics IPO June 25, 2025 Biocon CEO Siddharth Mittal said there are no immediate plans for a Syngene stake sale or Biocon Biologics IPO. The INR 4,500 Cr QIP will repay PE investors from the Viatris deal. Net debt stays at $1.1 Bn, but interest costs are set to drop 9-10% from next fiscal. Promoter stake falls to 54%, but majority control will be maintained.